<DOC>
	<DOCNO>NCT00674505</DOCNO>
	<brief_summary>To evaluate procedural safety filter efficiency FiberNet® Embolic Protection System use conjunction Boston Scientific Express SD Stent System primary stenting ostial atherosclerotic renal lesion patient atherosclerotic renal artery stenosis .</brief_summary>
	<brief_title>Safety &amp; Performance Study Lumen Biomedical 's FiberNet Distal Protection System Treatment Renal Artery Stenosis</brief_title>
	<detailed_description />
	<criteria>1 . Age ≥ 18 ≤ 85 year . 2 . Subject subject 's legal representative inform nature study , agree participate sign IRB approve consent form . 3 . Subject understands duration study 's follow visit requirement . 4 . Unilateral bilateral atherosclerotic de novo renal artery stenosis ( RAS ) associate follow : 1 . SBP &gt; 140 despite ≥3 antihypertensive medication 2 . Estimated Glomerular Filtration Rate ( eGFR ) ≥30≤70 cc/min calculate use Modified Diet Renal Disease ( MDRD ) formula 3 . Recurrent episodes decompensated heart failure 4 . Recurrent episodes `` flash '' pulmonary edema Angiographic Inclusion Criteria 1 . ≥70 % &lt; 100 % renal artery stenosis ( visual estimate ) involve unilateral , bilateral renal artery solitary renal artery . 2 . Renal poletopole length &gt; 7cm . 3 . Lesion ≤15 mm aortoostial junction . 4 . Renal artery reference lumen diameter ≥3.5 ≤7 mm FiberNet placement . Clinical Exclusion Criteria 1 . Estimated life expectancy &lt; 12 month . 2 . Estimated Glomerular Filtration Rate ( eGFR ) &lt; 30 cc/min . 3 . Renal poletopole length &lt; 7cm side diseased kidney . 4 . No history transplant kidney polycystic kidney disease . 5 . Uncontrolled hypercoagulability . 6 . Known allergy sensitivity heparin , aspirin , anticoagulant/antiplatelet therapy , nitinol stainless steel . 7 . Known allergy contrast medium adequately premedicated prior study procedure . 8 . Patient refuse possible temporary permanent hemodialysis . 9 . Refuses possible surgery repair access site renal artery . 10 . Known severe coronary carotid disease likely require surgical treatment enrollment followup period . 11 . Uncompensated congestive heart failure . 12 . Current enrollment investigational study wherein patient participation complete . 13 . Cardiovascular surgical cardiovascular interventional procedure ( include , limited , aortic , renal , cardiac , carotid , femoropopliteal , knee ) within 30 day prior enrollment study . 14 . Planned predict cardiovascular surgical interventional procedure outside affected renal artery ( include , limited , aortic , renal , cardiac , carotid , contralateral femoropopliteal , contralateral knee ) within 30 day entry study prior completion 30 day followup . 15 . Pregnancy , breastfeed plan become pregnant female child bear potential . 16 . Any patient opinion investigator would good candidate enrollment . Angiographic Exclusion Criteria 1 . Early bifurcation main renal artery prevent complete embolic protection kidney FiberNet . 2 . Fibromuscular Dysplasia . 3 . Presence thrombus lesion site . 4 . Nonostial atherosclerosis ( lesion &gt; 15mm renal ostium ) . 5 . Subintimal guidewire placement result dissection renal artery aorta , perforation renal artery aorta prior deployment device . 6 . Severe calcification likely prevent passage device .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2010</verification_date>
</DOC>